Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

Clinical trial NCT07385989 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07385989
Sponsor: WEI XU
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma

Start date: 2026-01-25
Primary completion: 2028-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.